Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ARIADME

Financiado

Cerrado

Analytical Research In ADME profiling ARIADME

The integration of absorption, distribution, metabolism and excretion (ADME) profiling into early drug discovery has been put forward as a strategy for reducing drug candidate attrition. Europe is challenged to develop novel ADME... ver más

30/09/2017

KU Leuven

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

KATHOLIEKE UNIVERSITEIT LEUVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-09-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

KU Leuven

0.00€ | Lider

N.D. | Participante

JANSSEN PHARMACEUTICA NV

N.D. | Participante

Proyectos interesantes

FutForm

Medical Technol...

Data Science

414K€ Cerrado

BIOSOL

Medical Technol...

Data Science

302K€ Cerrado

UNAH13-4E-2006

Medical Technol...

Data Science

20K€ Cerrado

METADRUG

Medical Technol...

Data Science

150K€ Cerrado

SAF2016-78756-P

Medical Technol...

Data Science

85K€ Cerrado

ORBITO

Medical Technol...

Data Science

25M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

KATHOLIEKE UNIVERSITEIT LEUVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The integration of absorption, distribution, metabolism and excretion (ADME) profiling into early drug discovery has been put forward as a strategy for reducing drug candidate attrition. Europe is challenged to develop novel ADME screening methodologies with increased efficiency and predictive power to profile the multitude of lead compounds currently being generated. The principal objective of this programme is to train a new generation of ADME scientists, equipped to tackle the challenge. To this end, a structured, interdisciplinary training programme is set up. The scientific aim of the programme is to improve and expand the current ADME profiling armamentarium by introducing 1) innovative in vitro and in vivo ADME tools 2) novel analytical methodologies and 3) new approaches for ADME data handling and computational modelling. State-of-the-art technologies are coupled with novel methodologies. All research projects rely to a great extent on analytical techniques. In addition to training-through-research, the programme provides a multi-stage training on a network-wide level as well as specialised local activities. The programme will enrol 13 early-stage researchers in a training consortium consisting of 4 academic and 2 industrial partners with worldwide recognised expertise. The trainees will develop in-depth insight and hands-on experience in ADME profiling, as well as scientific breadth and transferable skills. The high degree of intersectoral collaboration and cross-fertilisation fills many of the gaps in current educational paradigms and widens the career perspectives of the trainees in different institutional sectors including education, government and industry. The programme will organise open dissemination events to facilitate the transfer of newly generated knowledge to the broader EU community. The combined goal of the training efforts and innovative research is to lead Europe to the frontline in ADME profiling and secure a leadership position therein.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores